Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 16, 2021; 9(32): 9970-9976
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9970
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9970
Time intervals | Blood pressure (mmHg) | Heart rate (bpm) | Antihypertensive drugs | Complications | ||
SP | DP | MBP | ||||
Pre-3 d1 | 178 | 74 | 109 | 87 | Valsartan 80 mg; hydrochlorothiazide; 12.5 mg; amlodipine besylate 10 mg | Headache |
Operation | 117 | 60 | 79 | 65 | None | None |
Post-1 d | 133 | 62 | 86 | 71 | Valsartan 80 mg; hydrochlorothiazide; 12.5 mg; amlodipine besylate 10 mg | None |
Post-2 d | 151 | 69 | 96 | 73 | Valsartan 80 mg; hydrochlorothiazide; 12.5 mg; amlodipine besylate 10 mg | None |
Post-3 d | 143 | 66 | 92 | 76 | valsartan 80 mg; hydrochlorothiazide; 12.5 mg; amlodipine besylate 10 mg | None |
Post-1 yr | 137 | 65 | 89 | 69 | Amlodipine besylate 10 mg | None |
Post-2 yr | 134 | 64 | 87 | 73 | Amlodipine besylate 10 mg | None |
Post-3 yr | 145 | 71 | 96 | 77 | Amlodipine besylate 10 mg | None |
Post-4 yr | 145 | 64 | 91 | 74 | None | None |
- Citation: Luo G, Zhu JJ, Yao M, Xie KY. Computed tomography-guided chemical renal sympathetic nerve modulation in the treatment of resistant hypertension: A case report. World J Clin Cases 2021; 9(32): 9970-9976
- URL: https://www.wjgnet.com/2307-8960/full/v9/i32/9970.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i32.9970